2024 annual financial data
Generate Biomedicines 2024 Operating margin
Generate Biomedicines 2024 operating margin with verified reported values.
Direct answer
Operating margin was -962.6%.
Operating income was -196,939,000 USD and net income was -173,771,000 USD.
Operating cash flow was -117,750,000 USD.
Get free Generate Biomedicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,459,000 USD
- Operating income
- -196,939,000 USD
- Net income
- -173,771,000 USD
- Operating cash flow
- -117,750,000 USD